Lam Douglas, Chong Kelvin, Shih Kendrick, Wan Kelvin H, Cheng Arthur
The Chinese University of Hong Kong, Hong Kong, China.
The University of Hong Kong, Hong Kong, China.
Ophthalmol Ther. 2025 May;14(5):815-833. doi: 10.1007/s40123-025-01129-8. Epub 2025 Mar 26.
Dry eye disease (DED) poses a significant and escalating public health challenge. Effective diagnosis is crucial for optimal management. However, current practices are complicated and time-consuming. This paper proposes a revised framework for diagnosing and treating in Hong Kong, explicitly tailored to the local healthcare context and incorporating insights from global consensus guidelines. The framework emphasizes a streamlined assessment strategy and prioritizes direct symptom-based questioning alongside objective tests. It also includes a simplified corneal staining grading scheme to reduce complexity, considering the limited consultation time available in Hong Kong. Furthermore, the framework clearly outlines the appropriate treatment options based on the disease's severity and etiological cause(s) and focuses on the need for long-term management through follow-up or referrals. By addressing the multifaceted nature of DED and considering local healthcare constraints, this framework seeks to enhance patient outcomes through timely diagnosis and accurate assessment and treatment of DED.
干眼症对公共卫生构成了重大且日益严重的挑战。有效的诊断对于优化治疗至关重要。然而，目前的做法既复杂又耗时。本文提出了一个适用于香港的诊断和治疗修订框架，该框架是专门针对当地医疗环境制定的，并纳入了全球共识指南中的见解。该框架强调简化评估策略，并将基于症状的直接问诊置于客观检查之上。考虑到香港可用于会诊的时间有限，它还包括一个简化的角膜染色分级方案以降低复杂性。此外，该框架根据疾病的严重程度和病因明确列出了适当的治疗选择，并强调通过随访或转诊进行长期管理的必要性。通过解决干眼症的多方面问题并考虑当地医疗限制，该框架旨在通过及时诊断以及对干眼症的准确评估和治疗来改善患者预后。
